Wednesday, July 14, 2010

F.D.A. Panel to Vote on Whether Avandia Should Stay on Market - NYTimes.com

I first saw the news about the FDA's discussion on whether to restrict Avandia, a diabetes drug, because of the dangerous side effects it can cause, yesterday when I was on the treadmill. One of the TVs at the gym showed a news report on the subject. Though I couldn't hear the audio of the TV report without plugging earphones into the attachment on the treadmill, there were enough printed "headlines" on the screen to give me the gist of the report. Today, I saw this article about Avandia, and the FDA's possible decision to restrict its sale or even withdraw it from the market, in the New York Times.

That made me all the more determined to stick with the new calorie count/exercise daily regimen. If diabetes is preventable in my case, then I'm darn well going to bust my tail preventing it, and if it isn't, then you can bet your bottom dollar that I won't go down without a battle.

No comments: